These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25847221)

  • 1. Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry.
    Ramos-Fransi A; Rojas-García R; Segovia S; Márquez-Infante C; Pardo J; Coll-Cantí J; Jericó I; Illa I;
    Eur J Neurol; 2015 Jul; 22(7):1056-61. PubMed ID: 25847221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis.
    Leuzzi G; Meacci E; Cusumano G; Cesario A; Chiappetta M; Dall'armi V; Evoli A; Costa R; Lococo F; Primieri P; Margaritora S; Granone P
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):e76-88; discussion e88. PubMed ID: 24525106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis crisis.
    Bershad EM; Feen ES; Suarez JI
    South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
    Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
    Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of myasthenic crisis.
    Berrouschot J; Baumann I; Kalischewski P; Sterker M; Schneider D
    Crit Care Med; 1997 Jul; 25(7):1228-35. PubMed ID: 9233752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.
    Nelke C; Stascheit F; Eckert C; Pawlitzki M; Schroeter CB; Huntemann N; Mergenthaler P; Arat E; Öztürk M; Foell D; Schreiber S; Vielhaber S; Gassa A; Stetefeld H; Schroeter M; Berger B; Totzeck A; Hagenacker T; Meuth SG; Meisel A; Wiendl H; Ruck T
    J Neuroinflammation; 2022 Apr; 19(1):89. PubMed ID: 35413850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases.
    Neumann B; Angstwurm K; Mergenthaler P; Kohler S; Schönenberger S; Bösel J; Neumann U; Vidal A; Huttner HB; Gerner ST; Thieme A; Steinbrecher A; Dunkel J; Roth C; Schneider H; Schimmel E; Fuhrer H; Fahrendorf C; Alberty A; Zinke J; Meisel A; Dohmen C; Stetefeld HR;
    Neurology; 2020 Jan; 94(3):e299-e313. PubMed ID: 31801833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute neuromuscular respiratory failure: a population-based study of aetiology and outcome in Northern Ireland.
    Carr AS; Hoeritzauer AI; Kee R; Kinney M; Campbell J; Hutchinson A; McDonnell GV
    Postgrad Med J; 2014 Apr; 90(1062):201-4. PubMed ID: 24534488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of myasthenic crisis in late life.
    Sellman MS; Mayer RF
    South Med J; 1985 Oct; 78(10):1208-10. PubMed ID: 4049040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
    Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis.
    Vijayan J; Menon D; Barnett C; Katzberg H; Lovblom LE; Bril V
    Muscle Nerve; 2021 Oct; 64(4):462-466. PubMed ID: 34235762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower number of plasma exchange sessions and glomerular filtration rate decline are associated with second relapses in patients with myasthenia gravis.
    Premuzic V; Bilic E; Sepec BI; Hancevic M; Bilic H; Sitas B; Sprljan Alfirev R; Jelakovic B
    Medicine (Baltimore); 2020 Feb; 99(6):e19100. PubMed ID: 32028436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis masquerading as dysphagia: unveiled by magnesium infusion.
    Klair JS; Rochlani YM; Meena NK
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24744075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenic crisis.
    Chaudhuri A; Behan PO
    QJM; 2009 Feb; 102(2):97-107. PubMed ID: 19060020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory failure as the initial presentation of myasthenia gravis.
    Marlowe FI; D'Angelo AJ
    Ear Nose Throat J; 1989 Jun; 68(6):472-3. PubMed ID: 2743900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: management of myasthenic crisis and perioperative care.
    Juel VC
    Semin Neurol; 2004 Mar; 24(1):75-81. PubMed ID: 15229794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
    Köhler W; Bucka C; Klingel R
    J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.
    Bourque PR; Pringle CE; Cameron W; Cowan J; Chardon JW
    PLoS One; 2016; 11(8):e0159993. PubMed ID: 27490101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.